幽門螺旋桿菌診斷市場報告：到 2030 年的趨勢、預測和競爭分析

幽門螺旋桿菌診斷的趨勢和預測

全球幽門螺旋桿菌診斷市場的未來看起來充滿希望，醫院、診斷實驗室和診所市場充滿機會。預計 2024 年至 2030 年，全球幽門螺旋桿菌診斷市場將以 4.8% 的複合年成長率成長。該市場的主要促進因素是對個人化抗生素治療的需求不斷成長、感染疾病發病率的增加、感染疾病知識的增加以及幽門螺旋桿菌感染檢測的成本效益的提高。

• 按類型分類，Lucintel 預計，由於胃病發病率不斷增加，需要新技術進步，試劑在預測期內仍將是最大的細分市場。
• 在這個市場的最終用途類別中，由於十二指腸潰瘍、胃癌、胃炎和胃潰瘍等疾病的發生率不斷增加，醫院可能仍然是最大的部分。
• 從地區來看，由於醫療保健基礎設施的改善、FDA、NIH 和 CDC 等機構採取的行動以及新興經濟體的存在，預計北美在預測期內將出現最高的成長。

幽門螺旋桿菌診斷市場的策略性成長機會

由於人們對未經治療的感染所帶來的健康風險的認知不斷提高，以及先進診斷技術的可用性不斷提高，幽門螺旋桿菌診斷市場提供了巨大的成長機會。由於全球醫療保健系統優先考慮胃病的早期檢測和預防，因此公司在這個不斷成長的市場中擴大其產品範圍具有巨大的潛力。透過利用新興技術並擴展到新的地區，公司可以開發以前服務不足的市場並改善患者的治療效果。

• 非侵入性診斷的擴展：專注於開發和行銷非侵入性診斷（例如呼吸檢測和糞便抗原測試）的公司可以利用其日益普及的機會。
• 新興市場：亞洲、非洲和拉丁美洲的新興市場存在著巨大的擴張機會，這些國家的醫療基礎設施正在改善，胃病負擔仍然很高。
• 個人化診斷和治療：個人化醫療的發展，包括考慮遺傳變異和抗菌素抗藥性模式的診斷，為成長提供了新的途徑。
• 與遠端醫療和數位健康的整合：將診斷測試與遠端醫療平台整合可以增強患者獲得醫療保健的機會，特別是在偏遠地區，並為診斷公司創造新的機會。
• 與醫療保健提供者的夥伴關係：與醫院、診所和製藥公司的策略夥伴關係關係開發全面的診斷和治療解決方案將推動市場成長。

幽門螺旋桿菌診斷市場的策略成長機會充足，特別是對於專注於擴大非侵入性診斷、瞄準新興市場和整合個人化醫療的公司。與醫療保健提供者合作並利用遠端醫療平台還可以擴大市場覆蓋範圍和患者獲得治療的機會。透過利用這些機會，公司可以將自己定位為快速成長的幽門螺旋桿菌診斷市場的領導者。

幽門螺旋桿菌診斷市場的促進因素與挑戰

幽門螺旋桿菌診斷市場受到多種因素的影響，包括人們對幽門螺旋桿菌病菌感染造成的健康風險的認知不斷提高，以及對準確和非侵入性診斷工具的需求不斷增加。然而，市場也面臨監管障礙、測試複雜性和市場競爭等挑戰。了解促進因素和挑戰對於相關人員在幽門螺旋桿菌診斷的競爭格局和發展中尋求成功至關重要。

市場促進因素：

• 胃病患病率不斷上升：與幽門螺旋桿菌病菌感染相關的胃潰瘍、胃炎和胃癌發病率不斷上升，推動了對診斷測試的需求。
• 轉向非侵入性測試：非侵入性測試，例如呼氣抗原測試和糞便抗原測試，由於其易於使用和提高患者舒適度而受到關注。
• 提高對幽門螺旋桿菌風險的認知：隨著人們對幽門螺旋桿菌在胃病中的作用的認知不斷增強，對早期檢測和有效治療的需求也隨之增加。
• 診斷技術進步：分子診斷領域的持續技術創新，例如 PCR 和次世代定序，使幽門螺旋桿菌檢測更快、更準確、侵入性更小。
• 改善醫療基礎設施：新興市場的成長機會：擴大發展中地區的醫療基礎設施正在改善診斷工具的取得。

市場挑戰

• 監管障礙：新診斷測試的監管核准流程複雜且耗時，減緩了創新解決方案的上市速度。
• 先進診斷的成本：與先進診斷技術相關的高成本可能會限制其採用，特別是在低收入地區和預算有限的醫療保健機構。
• 診斷準確性和假陽性：儘管取得了進步，一些診斷方法仍然存在準確性問題，可能導致假陽性和假陰性，使患者管理複雜化。

幽門螺旋桿菌診斷市場是由早期檢測需求的增加、向非侵入性檢測的轉變以及診斷技術的進步所推動的。然而，挑戰仍然存在，包括監管障礙、成本以及與其他測試方法的競爭。透過應對這些挑戰並利用關鍵的市場促進因素，公司可以駕馭不斷變化的格局並抓住這個重要的胃腸道健康領域的成長機會。

目錄

第1章執行摘要

第2章全球幽門螺旋桿菌診斷市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球幽門螺旋桿菌診斷市場趨勢（2018-2023）與預測（2024-2030）
• 按類型分類的幽門螺旋桿菌診斷市場
  • 裝置
  • 試劑
  • 服務
• 幽門螺旋桿菌診斷的全球市場：依技術分類
  • 免疫檢測
  • POC測試
  • 分子診斷
• 全球幽門螺旋桿菌診斷市場規模（依最終用途）
  • 醫院
  • 診斷實驗室
  • 診所

第4章 2018-2030年區域市場趨勢及預測分析

• 按地區分類的幽門螺旋桿菌診斷市場
• 北美幽門螺旋桿菌診斷市場
• 歐洲幽門螺旋桿菌診斷市場
• 亞太地區幽門螺旋桿菌診斷市場
• 其他地區幽門螺旋桿菌診斷市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球幽門螺旋桿菌診斷市場成長機會（按類型）
  • 全球幽門螺旋桿菌診斷市場的技術成長機會
  • 全球幽門螺旋桿菌診斷市場成長機會（依最終用途）
  • 全球幽門螺旋桿菌診斷市場區域成長機會
• 全球幽門螺旋桿菌診斷市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球幽門螺旋桿菌診斷市場的產能
  • 全球幽門螺旋桿菌診斷市場的合併、收購和合資企業
  • 認證和許可

第7章主要企業概況

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic Trends and Forecast

The future of the global helicobacter pylori diagnostic market looks promising with opportunities in the hospital, diagnostic laboratory, and clinic markets. The global helicobacter pylori diagnostic market is expected to grow with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are the growing need for individualized antibiotic treatment, the increase of infectious illnesses, as well as, rising knowledge of infections and enhanced cost-effectiveness of helicobacter pylori infection detection.

• Lucintel forecasts that, within the type category, reagents will remain the largest segment over the forecast period due to increasing occurrences of gastric diseases necessitating new technological advancements.
• Within this market, within the end-use category, hospitals will remain the largest segment due to the increasing incidence of conditions like duodenal ulcers, stomach cancer, gastritis, and gastric ulcers.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the creation of the healthcare infrastructure, actions taken by agencies like the FDA, NIH, and CDC, and the existence of developed economies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Helicobacter Pylori Diagnostic Market

The Helicobacter pylori (H. pylori) diagnostic market has been experiencing significant transformations due to new technologies, improved diagnostic methods, and evolving healthcare needs. With H. pylori being a major cause of gastric ulcers and a key risk factor for gastric cancer, the demand for rapid, accurate, and non-invasive diagnostic tools continues to rise. Emerging trends in this field focus on enhancing test accuracy, speed, and patient convenience, while also reducing costs and improving accessibility to diagnostics in underserved regions.

• Advancements in Non-Invasive Testing: There is a growing adoption of non-invasive testing methods such as breath tests and stool antigen tests, which provide quicker and more comfortable alternatives to invasive biopsy procedures.
• Integration of Point-of-Care (POC) Testing: The development of portable, easy-to-use POC diagnostic devices is making H. pylori testing more accessible, especially in remote or rural areas.
• Rise of Molecular Diagnostics: Molecular techniques, such as PCR-based tests, are gaining popularity for their high sensitivity and accuracy in detecting H. pylori, particularly in complex or hard-to-diagnose cases.
• Focus on Personalized Medicine: Tailoring diagnostic tests to individual patient's needs, such as genetic susceptibility and antimicrobial resistance patterns, is becoming a key trend in H. pylori diagnostics.
• Increasing Use of Artificial Intelligence (AI): AI and machine learning algorithms are being integrated into diagnostic platforms to improve the speed and accuracy of H. pylori detection and interpretation of results.

Emerging trends in the H. pylori diagnostic market indicate a shift toward non-invasive, rapid, and highly accurate diagnostic methods, with a strong focus on accessibility and cost-effectiveness. Advances in molecular diagnostics, point-of-care devices, and AI integration will drive the next generation of H. pylori diagnostic tools. These innovations are set to significantly improve patient outcomes and expand the availability of diagnostic services globally, particularly in underserved regions.

Recent Developments in the Helicobacter Pylori Diagnostic Market

Recent developments in the Helicobacter pylori diagnostic market reflect a growing emphasis on improving the accuracy, speed, and patient experience in detecting H. pylori infections. Advances in testing technology, along with the increasing recognition of the link between H. pylori and various gastric diseases, are driving growth in the diagnostic sector. This section highlights key innovations and trends that are shaping the future of H. pylori diagnosis.

• Introduction of Advanced Breath Tests: The development of more sophisticated and accurate breath tests, such as those using isotope-labeled carbon, has improved the non-invasive detection of H. pylori infection.
• Novel Stool Antigen Tests: New, more sensitive stool antigen tests are improving diagnostic accuracy and are now being adopted for both initial diagnosis and post-treatment monitoring of H. pylori infections.
• Increased Focus on Rapid Diagnostic Kits: The market has seen the emergence of rapid diagnostic kits that provide quick results, reducing the need for laboratory-based analysis and enhancing patient convenience.
• AI-Assisted Diagnostics: Machine learning algorithms are increasingly being applied to assist in interpreting diagnostic results, improving both the accuracy and speed of diagnosing H. pylori infections.
• Collaborations with Research Institutions: Strategic collaborations between diagnostic companies and research institutions are facilitating the development of next-generation diagnostic tools, including tests that can identify antimicrobial resistance in H. pylori strains.

Recent developments in the H. pylori diagnostic market are largely driven by advancements in non-invasive testing technologies, including breath and stool antigen tests, as well as the integration of AI and machine learning into diagnostic platforms. These innovations not only enhance diagnostic accuracy and speed but also improve the patient experience. As the demand for quick and reliable H. pylori testing grows, the market is likely to see continued progress in both technology and accessibility.

Strategic Growth Opportunities for Helicobacter Pylori Diagnostic Market

The helicobacter pylori diagnostic market presents significant growth opportunities, driven by rising awareness of the health risks associated with untreated infections and the increasing availability of advanced diagnostic technologies. As global healthcare systems prioritize early detection and prevention of gastric diseases, there is substantial potential for companies to expand their offerings in this growing market. By leveraging emerging technologies and expanding into new regions, companies can tap into previously underserved markets and improve patient outcomes.

• Expansion of Non-Invasive Diagnostics: Companies focusing on the development and distribution of non-invasive diagnostic methods, such as breath tests and stool antigen tests, can capitalize on their growing popularity.
• Emerging Markets: There is a strong opportunity for expansion into emerging markets in Asia, Africa, and Latin America, where healthcare infrastructure is improving and the burden of gastric diseases remains high.
• Personalized Diagnostics and Treatment: The move toward personalized medicine, including diagnostics that take into account genetic variations and antimicrobial resistance patterns, offers new avenues for growth.
• Integration with Telemedicine and Digital Health: Integrating diagnostic tests with telemedicine platforms can enhance patient access to care, especially in remote areas, and create new business opportunities for diagnostic companies.
• Partnerships with Healthcare Providers: Strategic partnerships with hospitals, clinics, and pharmaceutical companies to develop comprehensive diagnostic and treatment solutions can boost market growth.

Strategic growth opportunities in the H. pylori diagnostic market are abundant, particularly for companies that focus on expanding non-invasive diagnostics, targeting emerging markets, and integrating personalized medicine. Collaborations with healthcare providers and leveraging telemedicine platforms will also enhance market reach and patient access to care. By capitalizing on these opportunities, companies can position themselves as leaders in the rapidly growing H. pylori diagnostic market.

Helicobacter Pylori Diagnostic Market Driver and Challenges

The helicobacter pylori diagnostic market is influenced by various factors, including the growing recognition of the health risks posed by H. pylori infections and the increasing demand for accurate and non-invasive diagnostic tools. However, the market also faces challenges, such as regulatory hurdles, the complexity of testing, and market competition. Understanding both the drivers and challenges is essential for stakeholders aiming to succeed in the competitive and evolving landscape of H. pylori diagnostics.

Market Drivers:

• Increased Prevalence of Gastric Diseases: The rising incidence of gastric ulcers, gastritis, and gastric cancer linked to H. pylori infections is driving the demand for diagnostic testing.
• Shift Toward Non-Invasive Testing: Non-invasive tests, such as breath and stool antigen tests, are gaining traction due to their ease of use and improved patient comfort.
• Growing Awareness of H. pylori Risks: As awareness about the role of H. pylori in gastric diseases increases, so does the demand for early detection and effective treatment.
• Technological Advancements in Diagnostics: Ongoing innovations in molecular diagnostics, such as PCR and next-generation sequencing, are making H. pylori detection faster, more accurate, and less invasive.
• Healthcare Infrastructure Development: Expanding healthcare infrastructure in developing regions is increasing access to diagnostic tools, creating growth opportunities in underserved markets.

Market Challenges:

• Regulatory Barriers: Regulatory approval processes for new diagnostic tests can be complex and time-consuming, slowing the time to market for innovative solutions.
• Cost of Advanced Diagnostics: High costs associated with advanced diagnostic technologies may limit adoption, particularly in low-income regions or healthcare settings with limited budgets.
• Diagnosis Accuracy and False Positives: Despite advances, some diagnostic methods still struggle with accuracy, leading to false positives or false negatives, which can complicate patient management.

The H. pylori diagnostic market is driven by increasing demand for early detection, the shift toward non-invasive testing, and advancements in diagnostic technology. However, challenges such as regulatory hurdles, cost considerations, and competition from other testing methods remain. By addressing these challenges and capitalizing on key market drivers, companies can navigate the evolving landscape and seize opportunities for growth in this important area of gastrointestinal health.

List of Helicobacter Pylori Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies helicobacter pylori diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the helicobacter pylori diagnostic companies profiled in this report include-

• Thermo Fisher Scientific
• Biohit
• Quest Diagnostics
• Meridian Bioscience
• Bio-Rad Laboratories
• Alpha Laboratories
• F. Hoffmann-La Roche
• Coris BioConcept
• Certest Biotec
• Epitope Diagnostics

Helicobacter Pylori Diagnostic by Segment

The study includes a forecast for the global helicobacter pylori diagnostic by type, technology, end use, and region.

Helicobacter Pylori Diagnostic Market by Type [Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents
• Services

Helicobacter Pylori Diagnostic Market by Technology [Analysis by Value from 2018 to 2030]:

• Immunoassays
• POC
• Molecular Diagnostics

Helicobacter Pylori Diagnostic Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostics Laboratories
• Clinics

Helicobacter Pylori Diagnostic Market by Region [Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Helicobacter Pylori Diagnostic Market

In recent years, the Helicobacter pylori (H. pylori) diagnostic market has been growing rapidly, driven by increasing awareness of gastrointestinal problems and the rising incidence of H. pylori-related conditions globally. Diagnostic innovations, particularly non-invasive tests and molecular diagnostics, have significantly improved the ease of detection and increased the rate of identification of this bacterium. The market's expansion is also supported by regulatory approvals of new diagnostic devices and increased collaboration among industry players. Regions such as the USA, China, Germany, India, and Japan are at the forefront of these trends, focusing on improving health indicators through advanced diagnostics.

• United States: The U.S. market has seen a breakthrough in H. pylori diagnostics with the introduction of non-invasive methods, especially polymerase chain reaction (PCR)-based techniques that target specific gene sequences to detect the presence of H. pylori DNA in bronchoalveolar lavage fluid (BALF). Breath and stool antigen tests have gained popularity due to their fast turnaround times, which enhance patient satisfaction. Additionally, new trends in biomolecular diagnostic techniques have led to clearer and more accurate diagnostic criteria. Future market growth is expected to be driven by approvals for advanced diagnostic kits, as well as collaborations between diagnostic manufacturers and healthcare providers to improve screening practices.
• China: The H. pylori diagnostic market in China is growing rapidly, thanks to increasing health consciousness and improved healthcare facilities. The market also forecasts a rising demand for portable and efficient cellular infectious disease testing kits. The Chinese government supports gastrointestinal disorder prevention programs, which further boosts market growth. Companies like Nogoer are focusing on the development of rapidly marketable and functional diagnostic solutions tailored to the population's needs.
• Germany: Although competition in Germany for H. pylori diagnostic tests is intense, it has not deterred customers from making substantial investments, as the country remains a leader in adopting new diagnostic technologies. More physicians are incorporating rapid tests and advanced molecular diagnostic kits into their practices. Germany's market is highly regulated, meaning only the most reliable and rugged diagnostic tools are approved for use. High priority is placed on research into novel diagnostic methods through collaborations between universities and biopharmaceutical firms, which helps promote better detection and treatment of patients.
• India: The H. pylori diagnostic market in India is booming due to the rising incidence of gastrointestinal disorders. Growing investments in healthcare facilities are facilitating the adoption of newer technologies, such as rapid antigen tests and molecular diagnostics. These solutions must remain affordable to accommodate the diverse patient population. Additionally, government initiatives aimed at improving the understanding of H. pylori as a disease are enabling earlier diagnoses and treatments, thereby expanding the scope of the market.
• Japan: The H. pylori diagnostic market in Japan is highly competitive, with a strong focus on technology and research and development (R&D). The introduction of new technologies, such as breath tests, aims to enhance patient comfort without compromising diagnostic accuracy. Japanese manufacturers are developing next-generation diagnostic kits with more functionalities and ease of use. Collaborations with universities and research institutions play a key role in addressing the challenges of H. pylori populations as part of the broader national health strategy.

Features of the Global Helicobacter Pylori Diagnostic Market

Market Size Estimates: Helicobacter pylori diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Helicobacter pylori diagnostic market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: Helicobacter pylori diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, technology, end use, and regions for the helicobacter pylori diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the helicobacter pylori diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the helicobacter pylori diagnostic market by type (instruments, reagents, and services), technology (immunoassays, POC, and molecular diagnostics), end use (hospitals, diagnostics laboratories, and clinics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Helicobacter Pylori Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Helicobacter Pylori Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Helicobacter Pylori Diagnostic Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Reagents
  • 3.3.3: Services
• 3.4: Global Helicobacter Pylori Diagnostic Market by Technology
  • 3.4.1: Immunoassays
  • 3.4.2: POC
  • 3.4.3: Molecular Diagnostics
• 3.5: Global Helicobacter Pylori Diagnostic Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostics Laboratories
  • 3.5.3: Clinics

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Helicobacter Pylori Diagnostic Market by Region
• 4.2: North American Helicobacter Pylori Diagnostic Market
  • 4.2.1: North American Market by Type: Instruments, Reagents, and Services
  • 4.2.2: North American Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.3: European Helicobacter Pylori Diagnostic Market
  • 4.3.1: European Market by Type: Instruments, Reagents, and Services
  • 4.3.2: European Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.4: APAC Helicobacter Pylori Diagnostic Market
  • 4.4.1: APAC Market by Type: Instruments, Reagents, and Services
  • 4.4.2: APAC Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics
• 4.5: ROW Helicobacter Pylori Diagnostic Market
  • 4.5.1: ROW Market by Type: Instruments, Reagents, and Services
  • 4.5.2: ROW Market by End Use: Hospitals, Diagnostics Laboratories, and Clinics

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Type
  • 6.1.2: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global Helicobacter Pylori Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Helicobacter Pylori Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Helicobacter Pylori Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Helicobacter Pylori Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Biohit
• 7.3: Quest Diagnostics
• 7.4: Meridian Bioscience
• 7.5: Bio-Rad Laboratories
• 7.6: Alpha Laboratories
• 7.7: F. Hoffmann-La Roche
• 7.8: Coris BioConcept
• 7.9: Certest Biotec
• 7.10: Epitope Diagnostics